<!doctype html><html lang=en-us><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=generator content="Wowchemy 5.7.0 for Hugo"><link rel=stylesheet href=/css/vendor-bundle.min.16f785cdb553c8c4431db6775122af35.css media=print onload='this.media="all"'><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/academicons@1.9.2/css/academicons.min.css integrity="sha512-KlJCpRsLf+KKu2VQa5vmRuClRFjxc5lXO03ixZt82HZUk41+1I0bD8KBSA0fY290ayMfWYI9udIqeOWSu1/uZg==" crossorigin=anonymous media=print onload='this.media="all"'><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/leaflet@1.7.1/dist/leaflet.min.css integrity crossorigin=anonymous media=print onload='this.media="all"'><link rel=stylesheet href=/css/wowchemy.5928d6f6b5eee121dc6141d2cdd0af46.css><link rel=stylesheet href=/css/libs/chroma/github-light.min.css title=hl-light media=print onload='this.media="all"'><link rel=stylesheet href=/css/libs/chroma/dracula.min.css title=hl-dark media=print onload='this.media="all"' disabled><meta name=author content="Christian Brueffer"><meta name=description content="**Background/Aim**<br />
Circulating tumor DNA (ctDNA), which is shed from cancer cells into the bloodstream, offers a potential minimally invasive approach for cancer diagnosis and monitoring. This research aimed to assess the preoperative ctDNA levels in ovarian tumors patients’ plasma and establish correlations with clinicopathological parameters and patient prognosis.<br />
**Patients and Methods**<br />
Tumor DNA was extracted from ovarian tumor tissue from 41 patients. Targeted sequencing using a panel of 127 genes recurrently mutated in cancer was performed to identify candidate somatic mutations in the tumor DNA. SAGAsafe digital PCR (dPCR) assays targeting the candidate mutations were used to measure ctDNA levels in patient plasma samples, obtained prior to surgery, to evaluate ctDNA levels in terms of mutant copy number/ml and variant allele frequency.<br />
**Results**<br />
Somatic mutations were found in 24 tumor samples, 17 of which were from ovarian cancer patients. The most frequently mutated gene was TP53. Preoperative plasma ctDNA levels were detected in 14 of the 24 patients. With higher stage, plasma ctDNA mutant concentration increased (p for trend <0.001). The overall survival of cancer patients with more than 10 ctDNA mutant copies/ml in plasma was significantly worse (p=0.008).<br />
**Conclusions**<br />
Pre-operative ctDNA measurement in ovarian cancer patients’ plasma holds promise as a predictive biomarker for tumor staging and prognosis."><link rel=alternate hreflang=en-us href=https://www.brueffer.io/publication/2023_ovarian_cancer_ctdna/><link rel=canonical href=https://www.brueffer.io/publication/2023_ovarian_cancer_ctdna/><link rel=manifest href=/manifest.webmanifest><link rel=icon type=image/png href=/media/icon_hu7422bdd1ad1d5b8840d6088d6ba7ed4c_15338_32x32_fill_lanczos_center_3.png><link rel=apple-touch-icon type=image/png href=/media/icon_hu7422bdd1ad1d5b8840d6088d6ba7ed4c_15338_180x180_fill_lanczos_center_3.png><meta name=theme-color content="#1565c0"><meta property="twitter:card" content="summary_large_image"><meta property="twitter:site" content="@cbrueffer"><meta property="twitter:creator" content="@cbrueffer"><meta property="twitter:image" content="https://www.brueffer.io/publication/2023_ovarian_cancer_ctdna/featured.jpg"><meta property="og:site_name" content="Christian Brueffer"><meta property="og:url" content="https://www.brueffer.io/publication/2023_ovarian_cancer_ctdna/"><meta property="og:title" content="Preoperative ctDNA Levels are Associated with Poor Overall Survival in Patients with Ovarian Cancer | Christian Brueffer"><meta property="og:description" content="**Background/Aim**<br />
Circulating tumor DNA (ctDNA), which is shed from cancer cells into the bloodstream, offers a potential minimally invasive approach for cancer diagnosis and monitoring. This research aimed to assess the preoperative ctDNA levels in ovarian tumors patients’ plasma and establish correlations with clinicopathological parameters and patient prognosis.<br />
**Patients and Methods**<br />
Tumor DNA was extracted from ovarian tumor tissue from 41 patients. Targeted sequencing using a panel of 127 genes recurrently mutated in cancer was performed to identify candidate somatic mutations in the tumor DNA. SAGAsafe digital PCR (dPCR) assays targeting the candidate mutations were used to measure ctDNA levels in patient plasma samples, obtained prior to surgery, to evaluate ctDNA levels in terms of mutant copy number/ml and variant allele frequency.<br />
**Results**<br />
Somatic mutations were found in 24 tumor samples, 17 of which were from ovarian cancer patients. The most frequently mutated gene was TP53. Preoperative plasma ctDNA levels were detected in 14 of the 24 patients. With higher stage, plasma ctDNA mutant concentration increased (p for trend <0.001). The overall survival of cancer patients with more than 10 ctDNA mutant copies/ml in plasma was significantly worse (p=0.008).<br />
**Conclusions**<br />
Pre-operative ctDNA measurement in ovarian cancer patients’ plasma holds promise as a predictive biomarker for tumor staging and prognosis."><meta property="og:image" content="https://www.brueffer.io/publication/2023_ovarian_cancer_ctdna/featured.jpg"><meta property="og:locale" content="en-us"><meta property="article:published_time" content="2023-11-30T00:00:00+00:00"><meta property="article:modified_time" content="2023-11-30T00:00:00+00:00"><script type=application/ld+json>{"@context":"https://schema.org","@type":"Article","mainEntityOfPage":{"@type":"WebPage","@id":"https://www.brueffer.io/publication/2023_ovarian_cancer_ctdna/"},"headline":"Preoperative ctDNA Levels are Associated with Poor Overall Survival in Patients with Ovarian Cancer","image":["https://www.brueffer.io/publication/2023_ovarian_cancer_ctdna/featured.jpg"],"datePublished":"2023-11-30T00:00:00Z","dateModified":"2023-11-30T00:00:00Z","author":{"@type":"Person","name":"Arturas Dobilas"},"publisher":{"@type":"Organization","name":"Christian Brueffer","logo":{"@type":"ImageObject","url":"https://www.brueffer.io/media/icon_hu7422bdd1ad1d5b8840d6088d6ba7ed4c_15338_192x192_fill_lanczos_center_3.png"}},"description":"**Background/Aim**\u003cbr /\u003e\nCirculating tumor DNA (ctDNA), which is shed from cancer cells into the bloodstream, offers a potential minimally invasive approach for cancer diagnosis and monitoring. This research aimed to assess the preoperative ctDNA levels in ovarian tumors patients’ plasma and establish correlations with clinicopathological parameters and patient prognosis.\u003cbr /\u003e\n**Patients and Methods**\u003cbr /\u003e\nTumor DNA was extracted from ovarian tumor tissue from 41 patients. Targeted sequencing using a panel of 127 genes recurrently mutated in cancer was performed to identify candidate somatic mutations in the tumor DNA. SAGAsafe digital PCR (dPCR) assays targeting the candidate mutations were used to measure ctDNA levels in patient plasma samples, obtained prior to surgery, to evaluate ctDNA levels in terms of mutant copy number/ml and variant allele frequency.\u003cbr /\u003e\n**Results**\u003cbr /\u003e\nSomatic mutations were found in 24 tumor samples, 17 of which were from ovarian cancer patients. The most frequently mutated gene was TP53. Preoperative plasma ctDNA levels were detected in 14 of the 24 patients. With higher stage, plasma ctDNA mutant concentration increased (p for trend \u003c0.001). The overall survival of cancer patients with more than 10 ctDNA mutant copies/ml in plasma was significantly worse (p=0.008).\u003cbr /\u003e\n**Conclusions**\u003cbr /\u003e\nPre-operative ctDNA measurement in ovarian cancer patients’ plasma holds promise as a predictive biomarker for tumor staging and prognosis."}</script><title>Preoperative ctDNA Levels are Associated with Poor Overall Survival in Patients with Ovarian Cancer | Christian Brueffer</title></head><body id=top data-spy=scroll data-offset=70 data-target=#TableOfContents class=page-wrapper data-wc-page-id=09f331d458cca4c723dff10ebddcaca6><script src=/js/wowchemy-init.min.ec9d49ca50e4b80bdb08f0417a28ed84.js></script><aside class=search-modal id=search><div class=container><section class=search-header><div class="row no-gutters justify-content-between mb-3"><div class=col-6><h1>Search</h1></div><div class="col-6 col-search-close"><a class=js-search href=# aria-label=Close><i class="fas fa-times-circle text-muted" aria-hidden=true></i></a></div></div><div id=search-box><input name=q id=search-query placeholder=Search... autocapitalize=off autocomplete=off autocorrect=off spellcheck=false type=search class=form-control aria-label=Search...></div></section><section class=section-search-results><div id=search-hits></div></section></div></aside><div class="page-header header--fixed"><header><nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id=navbar-main><div class=container-xl><div class="d-none d-lg-inline-flex"><a class=navbar-brand href=/>Christian Brueffer</a></div><button type=button class=navbar-toggler data-toggle=collapse data-target=#navbar-content aria-controls=navbar-content aria-expanded=false aria-label="Toggle navigation">
<span><i class="fas fa-bars"></i></span></button><div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none"><a class=navbar-brand href=/>Christian Brueffer</a></div><div class="navbar-collapse main-menu-item collapse justify-content-start" id=navbar-content><ul class="navbar-nav d-md-inline-flex"><li class=nav-item><a class=nav-link href=/><span>About Me</span></a></li><li class=nav-item><a class=nav-link href=/#consulting><span>Consulting</span></a></li><li class=nav-item><a class=nav-link href=/#posts><span>Posts</span></a></li><li class=nav-item><a class=nav-link href=/#projects><span>Projects</span></a></li><li class=nav-item><a class=nav-link href=/event/><span>Talks</span></a></li><li class="nav-item dropdown"><a href=# class="nav-link dropdown-toggle" data-toggle=dropdown aria-haspopup=true><span>Research</span><span class=caret></span></a><div class=dropdown-menu><a class=dropdown-item href=/#tags><span>Popular Topics</span></a>
<a class=dropdown-item href=/#featured><span>Featured Publications</span></a>
<a class=dropdown-item href=/#publications><span>Recent Publications</span></a>
<a class=dropdown-item href=/publication/><span>All Publications</span></a></div></li><li class=nav-item><a class=nav-link href=/#contact><span>Contact</span></a></li></ul></div><ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2"><li class=nav-item><a class="nav-link js-search" href=# aria-label=Search><i class="fas fa-search" aria-hidden=true></i></a></li><li class="nav-item dropdown theme-dropdown"><a href=# class=nav-link data-toggle=dropdown aria-haspopup=true aria-label="Display preferences"><i class="fas fa-moon" aria-hidden=true></i></a><div class=dropdown-menu><a href=# class="dropdown-item js-set-theme-light"><span>Light</span></a>
<a href=# class="dropdown-item js-set-theme-dark"><span>Dark</span></a>
<a href=# class="dropdown-item js-set-theme-auto"><span>Automatic</span></a></div></li></ul></div></nav></header></div><div class=page-body><div class=pub><div class="article-container pt-3"><h1>Preoperative ctDNA Levels are Associated with Poor Overall Survival in Patients with Ovarian Cancer</h1><div class=article-metadata><div><span>Arturas Dobilas</span>, <span>Yilun Chen</span>, <span class=author-highlighted>Christian Brueffer</span>, <span>Pia Leandersson</span>, <span>Lao H. Saal</span>, <span>Christer Borgfeldt</span></div><span class=article-date>November, 2023</span></div><div class="btn-links mb-3"><a class="btn btn-outline-primary btn-page-header" href=https://doi.org/10.21873/cgp.20423 target=_blank rel=noopener>DOI</a>
<a class="btn btn-outline-primary btn-page-header" href=https://cgp.iiarjournals.org/content/cgp/20/6suppl/763.full.pdf target=_blank rel=noopener><i class="fas fa-file-pdf mr-1"></i>PDF</a></div></div><div class="article-header article-container featured-image-wrapper mt-4 mb-4" style=max-width:330px;max-height:440px><div style=position:relative><img src=/publication/2023_ovarian_cancer_ctdna/featured_hub07240ecfcf7d03ca366287b763a2b16_43592_720x2500_fit_q75_h2_lanczos.webp width=330 height=440 alt class=featured-image></div></div><div class=article-container><h3>Abstract</h3><p class=pub-abstract><strong>Background/Aim</strong><br>Circulating tumor DNA (ctDNA), which is shed from cancer cells into the bloodstream, offers a potential minimally invasive approach for cancer diagnosis and monitoring. This research aimed to assess the preoperative ctDNA levels in ovarian tumors patients’ plasma and establish correlations with clinicopathological parameters and patient prognosis.<br><strong>Patients and Methods</strong><br>Tumor DNA was extracted from ovarian tumor tissue from 41 patients. Targeted sequencing using a panel of 127 genes recurrently mutated in cancer was performed to identify candidate somatic mutations in the tumor DNA. SAGAsafe digital PCR (dPCR) assays targeting the candidate mutations were used to measure ctDNA levels in patient plasma samples, obtained prior to surgery, to evaluate ctDNA levels in terms of mutant copy number/ml and variant allele frequency.<br><strong>Results</strong><br>Somatic mutations were found in 24 tumor samples, 17 of which were from ovarian cancer patients. The most frequently mutated gene was TP53. Preoperative plasma ctDNA levels were detected in 14 of the 24 patients. With higher stage, plasma ctDNA mutant concentration increased (p for trend &lt;0.001). The overall survival of cancer patients with more than 10 ctDNA mutant copies/ml in plasma was significantly worse (p=0.008).<br><strong>Conclusions</strong><br>Pre-operative ctDNA measurement in ovarian cancer patients’ plasma holds promise as a predictive biomarker for tumor staging and prognosis.</p><div class=row><div class=col-md-1></div><div class=col-md-10><div class=row><div class="col-12 col-md-3 pub-row-heading">Type</div><div class="col-12 col-md-9"><a href=/publication/#2>Journal article</a></div></div></div><div class=col-md-1></div></div><div class="d-md-none space-below"></div><div class=row><div class=col-md-1></div><div class=col-md-10><div class=row><div class="col-12 col-md-3 pub-row-heading">Publication</div><div class="col-12 col-md-9"><em>Cancer Genomics & Proteomics, 2023. 20(6suppl):763-770</em></div></div></div><div class=col-md-1></div></div><div class="d-md-none space-below"></div><div class=space-below></div><div class=article-style><html><style>section{background:#fff;color:#000;border-radius:1em;padding:1em;left:50%}#inner{display:inline-block;display:flex;align-items:center;justify-content:center}</style><section><div id=inner><script type=text/javascript src=https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js></script>
<span style=float:left ; class=__dimensions_badge_embed__ data-doi=https://doi.org/10.21873/cgp.20423 data-hide-zero-citations=true data-legend=always></span><script async src=https://badge.dimensions.ai/badge.js></script><div style=float:right ; data-link-target=_blank data-badge-details=right data-badge-type=medium-donut data-doi=https://doi.org/10.21873/cgp.20423 data-condensed=true data-hide-no-mentions=true class=altmetric-embed></div></div></section></div><div class=article-tags><a class="badge badge-light" href=/tag/cancer/>Cancer</a>
<a class="badge badge-light" href=/tag/ovarian-cancer/>Ovarian Cancer</a>
<a class="badge badge-light" href=/tag/liquid-biopsy/>Liquid Biopsy</a>
<a class="badge badge-light" href=/tag/targeted-sequencing/>Targeted Sequencing</a>
<a class="badge badge-light" href=/tag/digital-pcr/>Digital PCR</a>
<a class="badge badge-light" href=/tag/bioinformatics/>Bioinformatics</a>
<a class="badge badge-light" href=/tag/ctdna/>ctDNA</a></div><div class=share-box><ul class=share><li><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.brueffer.io%2Fpublication%2F2023_ovarian_cancer_ctdna%2F&text=Preoperative+ctDNA+Levels+are+Associated+with+Poor+Overall+Survival+in+Patients+with+Ovarian+Cancer" target=_blank rel=noopener class=share-btn-twitter aria-label=twitter><i class="fab fa-twitter"></i></a></li><li><a href="https://www.facebook.com/sharer.php?u=https%3A%2F%2Fwww.brueffer.io%2Fpublication%2F2023_ovarian_cancer_ctdna%2F&t=Preoperative+ctDNA+Levels+are+Associated+with+Poor+Overall+Survival+in+Patients+with+Ovarian+Cancer" target=_blank rel=noopener class=share-btn-facebook aria-label=facebook><i class="fab fa-facebook"></i></a></li><li><a href="mailto:?subject=Preoperative%20ctDNA%20Levels%20are%20Associated%20with%20Poor%20Overall%20Survival%20in%20Patients%20with%20Ovarian%20Cancer&body=https%3A%2F%2Fwww.brueffer.io%2Fpublication%2F2023_ovarian_cancer_ctdna%2F" target=_blank rel=noopener class=share-btn-email aria-label=envelope><i class="fas fa-envelope"></i></a></li><li><a href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fwww.brueffer.io%2Fpublication%2F2023_ovarian_cancer_ctdna%2F&title=Preoperative+ctDNA+Levels+are+Associated+with+Poor+Overall+Survival+in+Patients+with+Ovarian+Cancer" target=_blank rel=noopener class=share-btn-linkedin aria-label=linkedin-in><i class="fab fa-linkedin-in"></i></a></li><li><a href="https://web.whatsapp.com/send?text=Preoperative+ctDNA+Levels+are+Associated+with+Poor+Overall+Survival+in+Patients+with+Ovarian+Cancer%20https%3A%2F%2Fwww.brueffer.io%2Fpublication%2F2023_ovarian_cancer_ctdna%2F" target=_blank rel=noopener class=share-btn-whatsapp aria-label=whatsapp><i class="fab fa-whatsapp"></i></a></li><li><a href="https://service.weibo.com/share/share.php?url=https%3A%2F%2Fwww.brueffer.io%2Fpublication%2F2023_ovarian_cancer_ctdna%2F&title=Preoperative+ctDNA+Levels+are+Associated+with+Poor+Overall+Survival+in+Patients+with+Ovarian+Cancer" target=_blank rel=noopener class=share-btn-weibo aria-label=weibo><i class="fab fa-weibo"></i></a></li></ul></div><div class="media author-card content-widget-hr"><a href=https://www.brueffer.io><img class="avatar mr-3 avatar-circle" src=/authors/cbrueffer/avatar_hu17f80c4ec327e7baf25f17a8159016b3_537581_270x270_fill_lanczos_center_3.png alt="Christian Brueffer"></a><div class=media-body><h5 class=card-title><a href=https://www.brueffer.io>Christian Brueffer</a></h5><h6 class=card-subtitle>Bioinformatician and Data Scientist</h6><p class=card-text>Freelance Bioinformatician and Data Scientist with interests including disease biology and diagnostics, particularly in cancer, and open source bioinformatics.</p><ul class=network-icon aria-hidden=true><li><a href=mailto:christian@brueffer.io><i class="fas fa-envelope"></i></a></li><li><a href=https://twitter.com/cbrueffer target=_blank rel=noopener><i class="fab fa-twitter"></i></a></li><li><a href=https://mastodon.social/@cbrueffer target=_blank rel=noopener><i class="fab fa-mastodon"></i></a></li><li><a href=https://www.linkedin.com/in/cbrueffer target=_blank rel=noopener><i class="fab fa-linkedin"></i></a></li><li><a href="https://scholar.google.com/citations?user=BFnR7W8AAAAJ" target=_blank rel=noopener><i class="ai ai-google-scholar"></i></a></li><li><a href=https://www.researchgate.net/profile/Christian_Brueffer2 target=_blank rel=noopener><i class="ai ai-researchgate"></i></a></li><li><a href=https://orcid.org/0000-0002-3826-0989 target=_blank rel=noopener><i class="ai ai-orcid"></i></a></li><li><a href=https://github.com/cbrueffer target=_blank rel=noopener><i class="fab fa-github"></i></a></li></ul></div></div></div></div></div><div class=page-footer><div class=container><footer class=site-footer><p class="powered-by copyright-license-text">© 2023 Christian Brueffer. This work is licensed under <a href=https://creativecommons.org/licenses/by-nc-nd/4.0 rel="noopener noreferrer" target=_blank>CC BY NC ND 4.0</a></p><p class="powered-by footer-license-icons"><a href=https://creativecommons.org/licenses/by-nc-nd/4.0 rel="noopener noreferrer" target=_blank aria-label="Creative Commons"><i class="fab fa-creative-commons fa-2x" aria-hidden=true></i>
<i class="fab fa-creative-commons-by fa-2x" aria-hidden=true></i>
<i class="fab fa-creative-commons-nc fa-2x" aria-hidden=true></i>
<i class="fab fa-creative-commons-nd fa-2x" aria-hidden=true></i></a></p><p class=powered-by>Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target=_blank rel=noopener>Wowchemy</a> — the free, <a href=https://github.com/wowchemy/wowchemy-hugo-themes target=_blank rel=noopener>open source</a> website builder that empowers creators.</p></footer></div></div><script src=/js/vendor-bundle.min.46271ef31da3f018e9cd1b59300aa265.js></script>
<script src=https://cdn.jsdelivr.net/npm/leaflet@1.7.1/dist/leaflet.min.js integrity crossorigin=anonymous></script>
<script id=search-hit-fuse-template type=text/x-template>
    <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
    </div>
  </script><script src=https://cdn.jsdelivr.net/gh/krisk/Fuse@v3.2.1/dist/fuse.min.js integrity="sha512-o38bmzBGX+hD3JHWUFCDA09btWaqrNmoJ3RXLlrysA7PP01Kgs4UlE4MhelE1v5dJR3+cxlR4qQlotsW7jKsnw==" crossorigin=anonymous></script>
<script src=https://cdn.jsdelivr.net/gh/julmot/mark.js@8.11.1/dist/jquery.mark.min.js integrity="sha512-mhbv5DqBMgrWL+32MmsDOt/OAvqr/cHimk6B8y/bx/xS88MVkYGPiVv2ixKVrkywF2qHplNRUvFsAHUdxZ3Krg==" crossorigin=anonymous></script>
<script id=page-data type=application/json>{"use_headroom":true}</script><script src=/js/wowchemy-headroom.db4755770454eb63685f8de785c0a172.js type=module></script>
<script src=/en/js/wowchemy.min.8621d706896ab6d11dd8fd7042e20931.js></script>
<script src=/js/wowchemy-map.a26e9d2f7238ba5b868384f1c5bc6477.js type=module></script><div id=modal class="modal fade" role=dialog><div class=modal-dialog><div class=modal-content><div class=modal-header><h5 class=modal-title>Cite</h5><button type=button class=close data-dismiss=modal aria-label=Close>
<span aria-hidden=true>&#215;</span></button></div><div class=modal-body><pre><code></code></pre></div><div class=modal-footer><a class="btn btn-outline-primary my-1 js-copy-cite" href=# target=_blank><i class="fas fa-copy"></i> Copy</a>
<a class="btn btn-outline-primary my-1 js-download-cite" href=# target=_blank><i class="fas fa-download"></i> Download</a><div id=modal-error></div></div></div></div></div><script src=/js/wowchemy-publication.68f8d7090562ca65fc6d3cb3f8f2d2cb.js type=module></script>
<script type=text/javascript src=https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js></script>
<script async src=https://badge.dimensions.ai/badge.js></script></body></html>